RecruitingPhase 1 / Phase 2NCT04094610
Blood
Anaplastic large cell lymphoma
23
studies recruiting now
as of 7 Sept 2026
453
studies registered in total
as of 7 Sept 2026
12
countries with a recruiting site
as of 7 Sept 2026
6 Aug 2026
most recent study posted
among recruiting studies
Recruiting trials
RecruitingPhase 1NCT07055477
A Phase I Trial Anti-CC Chemokine Receptor 4 Chimeric Antigen Receptor T Cells (CCR4 CAR T Cells) for CCR4 Expressing T-cell Malignancies Including Peripheral T-cell Non-Hodgkin Lymphoma (PTCL) and Cutaneous T-cell Non-Hodgkin Lymphoma (CTCL)
RecruitingPhase 3NCT06724237
Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy
RecruitingEarly phase 1NCT03719105
Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma
RecruitingNCT07750886
Sample Collection for Ongoing Research and Product Evaluation Study - Non-Hodgkin Lymphoma (SCORE-NHL)
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 23 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Anaplastic large cell lymphoma study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Anaplastic large cell lymphoma
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Treatments being studied
2 approved treatments and 10 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Approved: Brentuximab Vedotin (Adcetris)Approved: Brigatinib (Alunbrig)
Phase 2Unecritinib
Phase 2Vinorelbine
Phase 2Crizotinib (Xalkori)
Phase 2Tanespimycin
Phase 2Ceritinib (Zykadia)
Phase 2Lorlatinib (Lorbrena)
Phase 2Sorafenib Tosylate (Nexavar)
Phase 2Ixabepilone (Ixempra kit)
+ 2 more in development
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).